
answers to your diabetes questions
Akesis Pharmaceuticals Doses First Patient in Phase IIa Trial of AKP ...
SAN DIEGO - (Business Wire) Akesis Pharmaceuticals, Inc. (OTCBB:AKES), an emerging diabetes drug-development company, today announced it has initiated dosing of patients in its placebo controlled Phase IIa trial for AKP-020, a novel vanadium compound ...
Tags: vanadium diabetes
in diabetes: benefit or harm?, by John Walsh, covers vanadium and other trace minerals in diabetes. can improve sensitivity to insulin in inflammatory diseases, cataracts, diabetes, cardiovascular diseases. beta-cells by vanadium: evidence for long-term amelioration of diabetes. References articles for vanadium it's link to diabetes and to normalizing blood glucose levels.
The role of in the management of diabetes. . .